Skip to main content

Table 2 Patient/tumor characteristics and the measured angles of the measurement target

From: Differences in the position of endometriosis-associated and non-associated ovarian cancer relative to the uterus

Variables

EAOC

Non-EAOC

All

P value for histology

P value for the angles

EC

CCC

MC

LGSC

HGSC

Patients (n)

20

52

12

1

34

121

  

Mean age ± SD (y)

61 ± 14

53 ± 13

48 ± 20

34 ± 0

53 ± 10

54 ± 14

0.05*

 

Tumor size ± SD (cm)

10 ± 4

13 ± 5

23 ± 8

16 ± 0

10 ± 5

13 ± 7

< 0.01*

 

Angles ± SD for each histology (°)

55 ± 38

52 ± 47

−15 ± 78

−118 ± 0

31 ± 54

38 ± 57

0.01*

 

Angles ± SD for EAOC or non-EAOC (°)

52 ± 45

16 ± 66

38 ± 57

 < 0.01*

    

Presence of endometriosis (n)

13 (65)

41 (76)

1 (8)

1 (100)

3 (9)

59 (49)

< 0.01*

0.06

Postmenopausal (n)

16 (80)

27 (53)

5 (42)

0

18 (53)

66 (55)

0.08

0.09

Anteverted uterus (n)

16 (80)

46 (88)

5 (42)

1 (100)

22 (65)

90 (74)

< 0.01*

< 0.01*

Multiparous (n)

14 (70)

28 (54)

7 (58)

0

29 (85)

78 (64)

< 0.01*

0.46

History of cesarean section (n)

3 (2)

4 (8)

2 (17)

0

2 (6)

11 (9)

0.48

0.38

History of abdominal surgery (n)

2 (1)

7 (13)

2 (17)

0

4 (12)

15 (12)

0.94

0.29

  1. Parentheses indicate percentages
  2. CCC, clear cell carcinoma; EC, endometrioid carcinoma; HGSC, high-grade serous carcinoma; LGSC, low-grade serous carcinoma; MC, mucinous carcinoma; SD, standard deviation
  3. *p < 0.05